SELLAS Life Sciences Group, Inc. (SLS)

4.335 +0.56 (+14.99%) USD  |  NASDAQ  |  Jan 02, 16:00
4.44 +0.10 (+2.42%) After-Hours: 18:59
More

SELLAS Life Sciences Group Change in Receivables (Quarterly)

Change in Receivables (Quarterly) Chart

View Change in Receivables (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Receivables (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Receivables (Quarterly) Range, Past 5 Years

View Change in Receivables (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Receivables (Quarterly) Benchmarks

View Change in Receivables (Quarterly) Benchmarks
Start Trial
GT Biopharma, Inc. --
Geron Corp. Upgrade
ADMA Biologics, Inc. Upgrade
Lyell Immunopharma, Inc. --
NovaBay Pharmaceuticals, Inc. Upgrade